Literature DB >> 12368991

Aromatic L-amino acid decarboxylase deficiency with hyperdopaminuria. Clinical and laboratory findings in response to different therapies.

A Fiumara1, C Bräutigam, K Hyland, R Sharma, L Lagae, B Stoltenborg, G F Hoffmann, J Jaeken, R A Wevers.   

Abstract

Aromatic L-amino acid decarboxylase (AADC - E.C. 4.1.1.28) converts L-dopa to dopamine and 5-hydroxytryptophan to serotonin. Inherited deficiency of this enzyme leads to decreased brain levels of these neurotransmitters. Clinically this results in the development of a progressive neurometabolic disorder characterized by severe hypotonia, dystonic and choreoathetoid movements, oculogyric crises, and hypothermia from infancy. Here we describe the clinical, biochemical and molecular details of two affected brothers, one of whom, despite the lack of AADC, presented with hyperdopaminuria. In addition, we detail his reactions to treatment with dopaminergic agonists, monoamine oxidase inhibitors and pyridoxine.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12368991     DOI: 10.1055/s-2002-34497

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  11 in total

1.  The paradox of hyperdopaminuria in aromatic L-amino Acid deficiency explained.

Authors:  Tessa Wassenberg; Leo A H Monnens; Ben P B H Geurtz; Ron A Wevers; Marcel M Verbeek; Michèl A A P Willemsen
Journal:  JIMD Rep       Date:  2011-11-02

2.  Report of two never treated adult sisters with aromatic L-amino Acid decarboxylase deficiency: a portrait of the natural history of the disease or an expanding phenotype?

Authors:  Vincenzo Leuzzi; Mario Mastrangelo; Agata Polizzi; Cristiana Artiola; André B P van Kuilenburg; Carla Carducci; Martino Ruggieri; Rita Barone; Barbara Tavazzi; Nico G G M Abeling; Lida Zoetekouw; Vito Sofia; Mario Zappia; Claudia Carducci
Journal:  JIMD Rep       Date:  2014-05-01

3.  Treatment of congenital neurotransmitter deficiencies by intracerebral ventricular injection of an adeno-associated virus serotype 9 vector.

Authors:  Ni-Chung Lee; Yin-Hsiu Chien; Min-Hsiu Hu; Wen-Shin Liu; Pin-Wen Chen; Wei-Hua Wang; Kai-Yuan Tzen; Barry J Byrne; Wuh-Liang Hwu
Journal:  Hum Gene Ther       Date:  2014-01-07       Impact factor: 5.695

4.  Diagnosis and treatment of neurotransmitter disorders.

Authors:  Phillip L Pearl; Thomas R Hartka; Jacob Taylor
Journal:  Curr Treat Options Neurol       Date:  2006-11       Impact factor: 3.598

5.  Urinary Neurotransmitter Patterns Are Altered in Canine Epilepsy.

Authors:  Teresa Schmidt; Sebastian Meller; Steven R Talbot; Benjamin A Berk; Tsz H Law; Sarah L Hobbs; Nina Meyerhoff; Rowena M A Packer; Holger A Volk
Journal:  Front Vet Sci       Date:  2022-05-16

6.  Aromatic L-amino acid decarboxylase deficiency: clinical features, drug therapy and follow-up.

Authors:  C Manegold; G F Hoffmann; I Degen; H Ikonomidou; A Knust; M W Laass; M Pritsch; E Wilichowski; F Hörster
Journal:  J Inherit Metab Dis       Date:  2009-01-28       Impact factor: 4.982

7.  Aromatic amino Acid decarboxylase deficiency not responding to pyridoxine and bromocriptine therapy: case report and review of response to treatment.

Authors:  Majid Alfadhel; Rana Kattan
Journal:  J Cent Nerv Syst Dis       Date:  2014-01-07

8.  Aromatic L-Amino acid decarboxylase deficiency: A new case from Turkey with a novel mutation.

Authors:  Kıvılcım Gücüyener; Ciğdem Seher Kasapkara; Leyla Tümer; Marcel M Verbeek
Journal:  Ann Indian Acad Neurol       Date:  2014-04       Impact factor: 1.383

Review 9.  Consensus guideline for the diagnosis and treatment of aromatic l-amino acid decarboxylase (AADC) deficiency.

Authors:  Tessa Wassenberg; Marta Molero-Luis; Kathrin Jeltsch; Georg F Hoffmann; Birgit Assmann; Nenad Blau; Angeles Garcia-Cazorla; Rafael Artuch; Roser Pons; Toni S Pearson; Vincenco Leuzzi; Mario Mastrangelo; Phillip L Pearl; Wang Tso Lee; Manju A Kurian; Simon Heales; Lisa Flint; Marcel Verbeek; Michèl Willemsen; Thomas Opladen
Journal:  Orphanet J Rare Dis       Date:  2017-01-18       Impact factor: 4.123

10.  Gene therapy improves motor and mental function of aromatic l-amino acid decarboxylase deficiency.

Authors:  Karin Kojima; Takeshi Nakajima; Naoyuki Taga; Akihiko Miyauchi; Mitsuhiro Kato; Ayumi Matsumoto; Takahiro Ikeda; Kazuyuki Nakamura; Tetsuo Kubota; Hiroaki Mizukami; Sayaka Ono; Yoshiyuki Onuki; Toshihiko Sato; Hitoshi Osaka; Shin-Ichi Muramatsu; Takanori Yamagata
Journal:  Brain       Date:  2019-02-01       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.